Brief: Perspective Therapeutics Initiates Phase 1/2a Clinical Trials For Two Targeted Alpha Therapy Oncology Product Candidates
21/06/2023 13:21
June 21 (Reuters) - Perspective Therapeutics Inc
CATX.A :
* PERSPECTIVE THERAPEUTICS INITIATES PHASE 1/2A CLINICAL
TRIALS
FOR TWO TARGETED ALPHA THERAPY ONCOLOGY PRODUCT CANDIDATES
* PERSPECTIVE THERAPEUTICS INITIATES PHASE 1/2A CLINICAL
TRIALS
FOR TWO TARGETED ALPHA THERAPY ONCOLOGY PRODUCT CANDIDATES
* PERSPECTIVE THERAPEUTICS INC - PRELIMINARY RESULTS FROM
INITIAL
COHORTS EXPECTED BY END OF 2023
Source text for Eikon: ID:nGNXGPdkP
Further company coverage: CATX.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise